← Open Payments lookup

KRISTI WEBER: Open Payments

NPI 1023207040 · YORK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$784 in 44 payments from 11 companies in 2025. Trend: 2023 $772 · 2024 $487 · 2025 $784

Food & beverage: $784
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$242
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$170
Teva Pharmaceuticals USA, Inc.6$119
ABBVIE INC.4$75
Neurocrine BioSciences, Inc.3$50
E.R. Squibb & Sons, L.L.C.2$31
ACADIA Pharmaceuticals Inc1$26
Supernus Pharmaceuticals, Inc.1$24
Biogen, Inc.1$16
Vanda Pharmaceuticals Inc.1$15

Products named: CAPLYTA, ABILIFY MAINTENA, REXULTI, AUSTEDO XR, VRAYLAR, INGREZZA, UZEDY, COBENFY.

Industry payments across NE — which companies pay providers there.